Clinical Trials Logo

Retinopathy clinical trials

View clinical trials related to Retinopathy.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05921981 Completed - Retinopathy Clinical Trials

Multisensory Stimulation Versus White Noise

Start date: May 10, 2023
Phase: N/A
Study type: Interventional

This study aimed to compare the effectiveness of two interventions, white noise, and multisensory stimulation, during retinopathy examinations on premature infants. Retinopathy is a common eye disorder among premature infants, which can cause visual impairments if not addressed. The research used a randomized controlled experimental design, with premature infants randomly assigned to either the white noise or multisensory stimulation group or control group. Physiological responses, behavioral indicators, and the pain of the retinopathy examination were measured. Trained healthcare professionals conducted the investigations in a controlled environment, and statistical analyses were employed to compare the outcomes between the three groups. The findings of this study have the potential to inform the development of more effective and well-tolerated examination protocols for premature infants, leading to improved visual outcomes and overall well-being for this vulnerable population.

NCT ID: NCT03901898 Completed - Diabetes Clinical Trials

Feasibility of an Intervention to Increase Diabetic Retinopathy Screening Attendance

Start date: July 16, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to test a way to support practices to improve attendance at retinopathy screening among people with diabetes. This new approach will be delivered to staff in general practice and involves: 1) briefing and audit training for practice staff; 2) electronic alerts on patient files to prompt GPs and nurses to remind patients, 3) face-to-face, phone and letter reminders and a brief information sheet for people with diabetes who have not attended screening, and; 4) payment to practices. The practice will carry out an audit to identify patients who have not attended screening, and re-audit at 6 months to identify any changes in attendance. The study will test this new approach over six months in eight different practices to determine whether it is feasible to deliver in a real-world setting. Four practices will be randomly assigned to receive the new approach straight away (intervention group), while the other four practices will be assigned to the group who wait, deliver care as usual, and roll out the new approach after six months (wait-list-control group). After the new approach has been tested for six months, the research team will use staff questionnaires, and carry out focus groups and interviews with patients and practice staff to learn about their experiences. The time and resources needed to deliver the approach will also be recorded to estimate the cost of delivering the new approach and how feasible it would be to carry out a larger study.

NCT ID: NCT02321904 Completed - Type 1 Diabetes Clinical Trials

Corneal Confocal Microscopy to Detect Diabetic Neuropathy in Children

CCM
Start date: June 2008
Phase:
Study type: Observational

The overall aim of this study is to confirm the utility of corneal confocal microscopy (CCM) as a new technique to rapidly and non-invasively assess diabetic neuropathy (DN) in children. This study will be divided into two phases: Phase 1 will be a cross-sectional study of children with type 1 diabetes and normal controls, while phase 2 will be a longitudinal assessment of a subgroup of children with type 1 diabetes recruited during Phase 1.

NCT ID: NCT01955135 Completed - Retinopathy Clinical Trials

Anesthesia for Retinopathy of Prematurity

Start date: September 2010
Phase: Phase 4
Study type: Interventional

Premature infants experience more respiratory problems after surgical procedures. The investigators aimed to compare general anesthesia with sedation on the need for post-operative mechanical ventilation in infants undergoing retinopathy of prematurity surgery.

NCT ID: NCT01793090 Completed - Genetic Disease Clinical Trials

EPI-743 in Cobalamin C Defect: Effects on Visual and Neurological Impairment

Start date: January 2013
Phase: Phase 2
Study type: Interventional

The aim of the research is to investigate the safety and efficacy of EPI-743 treatment in patients with Cbl-C defect and related visual and neurological impairment. Primary Endpoints will be the improvement in visual function as assessed by visual acuity and eye-hand coordination and manual dexterity. Secondary Endpoints will be the improvement in neurologic function, evaluated by a battery of age-appropriated psychophysical tests, and/or in objective electrophysiological tests such as Visual Evoked potentials (VEP) and Electroretinogram (ERG) and/or the change in serum markers of redox state.

NCT ID: NCT01412905 Completed - Diabetes Clinical Trials

Telemedicine Retinal Screening Utilizing a Mobile Medical Unit

Start date: February 2007
Phase:
Study type: Observational

Objective: To test the accuracy of a referral system for diabetic eye disease conducted by a trained screener using a digital camera, a mobile medical unit and a centralized image-storing software in underserved, ethnically diverse neighborhoods in San Diego. Methods and Research Design: Retinal screening exams were offered at 8 community health centers for 1229 individuals, ages 16-80 years with diabetes throughout San Diego County over 18 months. Images were captured with a special digital camera, securely transferred to a software system and read independently by a trained technician and retinal specialist. An analysis was conducted to evaluate who had severe eye disease and how accurate the reading of the technician were compared to the expert ophthalmologist readings. The investigators would like to demonstrate that telemedicine retinal screening utilizing a mobile medical unit with a trained technician in high-risk, ethnically diverse populations can accurately detect positive and negative disease. This may be a model to increase access to retinal examination in order to meet current guidelines and can allow more efficient use of the retinal specialist to evaluate and treat disease leading to a more cost efficient method of care.

NCT ID: NCT00828425 Completed - Diabetes Mellitus Clinical Trials

Management of Diabetes Mellitus Patients With Retinopathy

Start date: December 2008
Phase: N/A
Study type: Observational

Aim of this NIS is to retrospectively document the management of diabetic patients with retinopathy in a naturalistic setting in Switzerland. Following elements are going to be analyzed: - which medication are used to keep blood pressure under control? - which medication are used for metabolic control? - the average control level of metabolism and blood pressure is compliant with the international guidelines? - laser photocoagulation plays a role in the control of metabolism and blood pressure? - there are differences in the control of metabolism and blood pressure between patients with DM I or DM II? - there is an influence of renal failure on the choose of medication?

NCT ID: NCT00259701 Completed - Diabetes Clinical Trials

Microvascular Reactivity.

Start date: June 2005
Phase: N/A
Study type: Observational

This study attempts to test capillary responses to various challenges without the need for iontophoresis (electrical current).